Al-Razi Medical Co. (9572.SR) — Income statement
Revenue, gross profit, operating income, net income, and EPS for Al-Razi Medical Co. — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 74↑21.2% | 61↑0.0% | 61↑17.1% | 52↑15.9% | 45 | |
| Cost of Revenue | 55↑23.1% | 45↑1.7% | 44↑13.4% | 39↑14.3% | 34 | |
| Gross Profit | 19↑16.3% | 17↑17.9% | 14↑3.9% | 14↑20.9% | 11 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 1↓2.6% | 1↑12.2% | 1 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 2↑4.4% | 2↑4.1% | 2↓80.7% | 9 | |
| SG&A Expenses | 0.00↓100.0% | 3↑1.5% | 3↑7.4% | 3↓67.3% | 9 | |
| Other Expenses | 18↑35.2% | 13↑41.6% | 9↑17.7% | 8 | 0.00 | |
| Operating Expenses | 18↑9.7% | 16↑31.7% | 12↑15.0% | 11↑24.5% | 9 | |
| Total Costs & Expenses | 73↑219.5% | -61↓201.7% | 60↑21.0% | 50↑16.4% | 43 | |
| Operating Results | ||||||
| Operating Income | 2↑262.2% | 0.43↓76.0% | 2↓37.3% | 3↑9.3% | 3 | |
| Depreciation & Amortization | 0.00↓100.0% | 2↓53.2% | 4↑30.9% | 3↑34.3% | 2 | |
| EBITDA | 2↑262.2% | 0.43↓91.4% | 5↓11.4% | 6↑11.7% | 5 | |
| EBIT | 2↑262.2% | 0.43↓72.2% | 2↓48.7% | 3↓2.7% | 3 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↑100.0% | -0.90↓88.8% | -0.48↓58.0% | -0.30↑49.5% | -0.60 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00↓100.0% | 0.90↑88.8% | 0.48↑58.0% | 0.30↓49.5% | 0.60 | |
| Non-Operating Income | 0.00↑100.0% | -0.61↓314.5% | -0.15↑3.7% | -0.15↑68.5% | -0.48 | |
| Other Income / Expenses | -2↓1756.0% | 0.10↑113.1% | -0.73↓56.2% | -0.47↓313.8% | -0.11 | |
| Income Before Tax | 0.00↓100.0% | 0.53↓51.2% | 1↓55.2% | 2↓4.3% | 3 | |
| Income Tax Expense | 0.00↓100.0% | 0.35↓11.5% | 0.40↓2.7% | 0.41↑11.0% | 0.37 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 0.00↓100.0% | 0.18↓74.4% | 0.69↓65.9% | 2↓6.9% | 2 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 0.82↑366.0% | 0.18↓74.4% | 0.69↓65.9% | 2↓6.9% | 2 | |
| Bottom-Line Net Income | 0.82↑366.0% | 0.18↓74.4% | 0.69↓65.9% | 2↓6.9% | 2 | |
| EPS (Basic) | 0.54↑350.0% | 0.12↓73.3% | 0.45↓66.2% | 1.33↓6.3% | 1.42 | |
| EPS (Diluted) | 0.54↑350.0% | 0.12↓73.3% | 0.45↓66.2% | 1.33↓6.3% | 1.42 | |
| Weighted Average Shares | 2↑3.6% | 1↓3.6% | 2↑0.0% | 2↑0.0% | 2 | |
| Weighted Average Diluted Shares | 2↑3.6% | 1↓3.6% | 2↑0.0% | 2↑0.0% | 2 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.